Clinical trials
Parkinson’s disease clinical trials
A movement disorder caused by the loss of dopamine-producing brain cells. We’re tracking 739 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06884722Recruiting
Brain study of social perception in Parkinson's disease
This study uses brain scans to understand how people with Parkinson's disease process social cues, like faces and emotions. It may help researchers learn more about how Parkinson's affects social thinking.
BronAges 30–75 - NCT06892717Recruiting
Caregiver burden in Parkinson's disease study
This study looks at how caring for someone with Parkinson's disease affects the caregiver. It aims to understand the challenges and needs of family members or friends who provide unpaid care.
Istanbul, BeylikdüzüAges 40–80 - NCT06893055Recruiting
Strength and endurance training for Parkinson's
This study tests a circuit training program that combines strength and endurance exercises to see if it helps people with Parkinson's disease improve their movement and daily function.
Prague, PragueAges 18–75 - NCT06901869Recruiting
Physical activity study for Parkinson's disease
This study explores how physical activity affects people with Parkinson's disease. It's open to anyone with mild to severe Parkinson's who wants to be more active.
Stockholm, SolnaAges Any age - NCT06906679Recruiting
Upper limb rehab for Parkinson's disease
This trial tests an upper limb rehabilitation program for people with Parkinson's disease. It aims to improve arm and hand function while on regular medication.
Cassino, FRAges 30–80 - NCT06908460Recruiting
Parkinson's nursing home staff training and quality of life study
This trial tests whether training nursing home staff can improve the quality of life for residents with Parkinson's disease. The training may help staff better support residents' specific needs.
GrenobleAges 18 years+ - NCT06916260Recruiting
Light therapy study for people with Parkinson's disease
This study tests whether light therapy can help people with Parkinson's disease. Participants will receive light therapy sessions and have their symptoms checked before, after, and three months later.
Newark, DelawareAges 50–80 - NCT06919822Recruiting
Spinal cord stimulation for Parkinson's disease
This trial tests whether targeted electrical stimulation of the spinal cord can improve movement and reduce symptoms in people with Parkinson's disease. It is for those who have had Parkinson's for at least five years, are still responding to levodopa but have motor fluctuations.
Fuzhou, FujianAges 40–75 - NCT06950255Recruiting
Cane training for walking in Parkinson's disease
This study tests whether learning to use a simple cane can improve walking in people with Parkinson's disease. You will be trained to use a cane and then your walking will be measured.
Belo Horizonte, Minas GeraisAges 40 years+ - NCT06955377Recruiting
Bending forward and airway protection in Parkinson's disease
This study looks at how bending forward (trunk flexion) affects your body's ability to protect your airway in Parkinson's disease. It may help understand breathing risks and guide therapy.
PragueAges 18 years+ - NCT06957405Recruiting
Mental practice for freezing in Parkinson's disease
This trial tests whether remote mental practice can help reduce freezing of gait in people with Parkinson's disease. If you experience freezing episodes, you may be able to participate from home through video calls.
São Paulo, São PauloAges Any age - NCT06977204Recruiting
Exercise and brain health in Parkinson's disease
This study looks at whether physical activity can reduce inflammation in the brain for people with Parkinson's disease. It aims to understand how exercise might help slow the progression of the disease.
Pavia, PaviaAges 40–80 - NCT06978920RecruitingPhase 1
Stem cell therapy for Parkinson's disease
This early-stage trial tests a new stem cell treatment called NCR201 for people with Parkinson's. It aims to see if the treatment is safe and might help improve symptoms.
Hefei, AnhuiAges 40–75 - NCT07001150RecruitingPhase 2
Silymarin for nerve protection and symptom control in Parkinson's
This trial tests if silymarin, a natural plant extract, can help protect nerves and improve symptoms in people with Parkinson's disease who are already taking dopamine replacement therapy. It aims to see if adding silymarin can provide extra benefits.
Tanta, Tanta, Qism 2Ages 45–65 - NCT07010328Recruiting
AI-guided posture training for Parkinson's disease
This trial tests whether a special training program that uses artificial intelligence can help improve posture in people with Parkinson's disease who have a forward bend or lean to one side. If you have Parkinson's and a noticeable postural problem, this might be a way to try a new approach to rehabilitation.
Pavullo nel Frignano, PaviaAges 18 years+ - NCT07010783Recruiting
Breathing exercises for Parkinson's disease
This study looks at how Parkinson's disease affects breathing. It tests exercises that might help people with Parkinson's breathe better and feel healthier.
AnkaraAges 50–80 - NCT07020026RecruitingPhase 2
Tau brain scan study for Parkinson's and related disorders
This study uses a special PET scan to measure tau protein buildup in the brain of people with Parkinson's disease (including those with a LRRK2 gene mutation), Progressive Supranuclear Palsy, or Corticobasal Syndrome. It aims to better understand how tau relates to these conditions.
New Haven, ConnecticutAges 45–85 - NCT07022522Recruiting
Brain stimulation frequencies for impulse control in Parkinson's
This study tests whether stimulating specific parts of the brain's subthalamic nucleus at different frequencies can improve control over unwanted movements or impulses in people with Parkinson's disease. If you are planning to have DBS surgery, this trial may help find a better way to use the device.
Beijing, Beijing MunicipalityAges 40–80 - NCT07023224Recruiting
Turkish Parkinson's Dyskinesia Scale Reliability Study
This study is testing a Turkish version of a scale that measures dyskinesias (involuntary, jerky movements caused by Parkinson's medication). If you have Parkinson's, experience dyskinesias, and are at a mild to moderate stage, you may be able to help researchers see if the translated scale works well.
Izmir, İ̇zmi̇rAges Any age - NCT07028515Recruiting
Motor learning and motivation study for Parkinson's
This trial examines how self-controlled practice affects motor learning and motivation in people with Parkinson's disease. It aims to determine if giving participants control over their practice schedule can improve their ability to learn and perform motor tasks.
Taipei, Zhongzheng Dist.Ages 20 years+ - NCT07057219Recruiting
Steps Against Parkinson's: walking exercise program
This trial tests a program to help people with Parkinson's disease improve their walking and balance through physical exercise. It's for people in early to moderate stages who have some walking trouble.
Randwick, New South WalesAges 18 years+ - NCT07102342RecruitingPhase 1/Phase 2
Cell therapy for Parkinson's disease
This trial tests a new cell treatment for Parkinson's disease. It involves injecting special cells into the brain to see if they can safely replace damaged cells and improve symptoms. It might help people who have had Parkinson's for several years and still respond well to medication.
New York, New YorkAges 30–75 - NCT07110376Recruiting
Brain recordings during sleep with deep brain stimulation for Parkinson's
This study looks at brain activity during sleep in people with Parkinson's who have a deep brain stimulation (DBS) device. It aims to understand how different DBS settings affect sleep, which may help improve treatment.
Cleveland, OhioAges 18 years+ - NCT07118956Recruiting
Ear stimulation for apathy in Parkinson's
This trial tests whether a gentle electrical stimulation on your ear (taVNS) can help improve low motivation (apathy) in people with Parkinson's. It also uses MRI scans to see how the treatment affects the brain.
Hefei, AnhuiAges 40–90
Hear when a new Parkinson’s disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for parkinson’s disease?
- Yes. Clin2 currently lists 739 recruiting parkinson’s disease studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a parkinson’s disease trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a parkinson’s disease trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.